semaglutide and metformin vs Efficacy safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial Yes – it's safe to

Do not give RYALTRIS to other people, even if they have the same symptoms that you have

1 year?) Why is weight loss important to you now

Major diabetes organizations, including the American Diabetes Association, recommend considering GLP-1 agonists in patients on metformin who have not reached their treatment targets, particularly those with cardiovascular disease or significant weight loss needs

Hypoglycemia: While rare in people without diabetes, an overlap can cause blood sugar to drop too low

Severity and Discontinuation 13 events were mild 7 events were moderate 1 event was severe and serious Two discontinuations, both in the 12 mg group: One due to QT interval prolongation One due to moderate palpitations Types of Reported Arrhythmia-Related Events (Frequency varies by dose

No guarantees, though